Research Article
Application of Antithrombotic Drugs in Different Age-Group Patients with Upper Gastrointestinal Bleeding
Table 5
Multivariate hazard regression analysis.
| | | value | OR | 95.0% CI–OR |
| Logistic analysis of rebleeding | | | | | Resumption of anticoagulants | 2.060 | 0.004 | 7.845 | 1.966–7.845 | Variceal hemorrhage | 3.516 | <0.001 | 33.65 | 5.265–33.650 | Black stool | | 0.014 | 0.216 | 0.064–0.216 | Hemoglobin (laboratory examination) | 0.052 | <0.001 | 1.053 | 1.028–1.053 | Platelets (laboratory examination) | 0.01 | <0.001 | 1.010 | 1.004–1.010 | Heart rate | | 0.012 | 0.972 | 0.951–0.972 | Cox analysis of death | | | | | CHF | 2.156 | <0.001 | 8.638 | 3.211–8.638 | Cirrhosis | 1.491 | 0.010 | 4.443 | 1.421–4.443 | Creatine kinase | 0.002 | <0.001 | 1.002 | 1.001–1.002 | Albumin | | 0.024 | 0.916 | 0.849–0.916 |
|
|
CHF: congestive heart failure.
|